Isogenica, Biolauncher and Cresset Biomolecular Discovery forge alliance to bring powerful target-to-drugs platform to market
Joint venture aims to rapidly identify small molecule therapeutics to pharma targets
29-Jun-2011 -
Isogenica Ltd announced a collaborative joint venture with Biolauncher Ltd and Cresset Biomolecular Discovery Ltd to develop an innovative end-to-end therapeutic discovery platform. Under the terms of the collaboration the parties will integrate their expertise in peptide library design, ...
Biolauncher
drug discovery
Isogenica
+1